National Comprehensive Cancer Network

About NCCN

NCCN Guideline Translations on

By Kelly Simpson, Manager, Global Initiatives

There is substantial international interest in NCCN. More than 44 percent of registered users are from outside the United States and approximately 50,000 global professionals access NCCN content via our Permissions Request tool. Further, there is demand for on-site and remote NCCN educational congresses and symposia across the globe. Through practical education programs, The Global Leadership Exchange Program, collaborations, and the development, maintenance, and distribution of clinical resources, NCCN aims to improve the quality and effectiveness of care for patients with cancer around the world. 

During live educational programs, which have been held in China, Japan, South Korea, and the United Arab Emirates, NCCN Guidelines Panel Chairs and Members address topics such as screening, staging, and therapeutic strategies for treating tumor types of various stages and for supportive care. In addition, multidisciplinary management approaches are discussed by medical oncologists, surgical oncologists, and radiation oncologists from world-recognized NCCN Member Institutions and leading foreign cancer centers during these highly interactive congresses. Local thought leaders elucidate their respective practice standards and treatment rationale for the regional patient populations, creating a highly comprehensive experience for attendees.

The NCCN Global Leadership Exchange Program features cancer center facility tours for visiting NCCN experts hosted by prominent local faculty. Patient rounds, tumor board participation, surgical observation, and presentations are often incorporated.  Reciprocally, Global Leadership Exchange programs have taken place at NCCN Member Institutions for foreign oncologists and hospital administrators.

The aforementioned activities promote international exchanges of knowledge, insights, and ideas for expanded awareness of successful approaches and best practices in delivery of care.  As a fundamental component of these exchanges, NCCN collaborates to provide expert-developed, evidence-based, regionally-applicable resources for clinicians, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™): Local Editions.  These country-specific NCCN Guidelines™ include adaptations which account for metabolic differences in populations, accessibility of technology, and regulatory status of health care technologies used in cancer management in the specified country. Designed to aid clinicians in determining appropriate and effective avenues of care in a specified country, The NCCN Guidelines: Local Editions are developed by the host country’s oncology thought leaders in conjunction with NCCN Guidelines Panels Members. Consensus deliberations to discussing considered modifications are thought-provoking and substantially valuable to all participants. 

NCCN and its collaborators have published The China Editions of the following NCCN Guidelines: Breast, Cervical, Colon, Gastric, Head & Neck, Kidney, Non-Small Cell Lung, Ovarian, Pancreatic, and Rectal Cancers and Non-Hodgkin’s Lymphomas. NCCN has also developed The Korea Editions of the Colon and Non-Small Cell Lung Cancer Guidelines. 

NCCN also collaborates to create NCCN Guidelines: Consensus Statements, which are manuscript statements outlining, describing, and rationalizing variations in care within a country or region, or across multiple countries within a region, as they compare to the recommendations of the NCCN Guidelines™. These Consensus Statements offer an exploratory and analytical account of the impact of genetic variations in metabolism of agents, regulatory environments, and practice standards of participating countries.  NCCN has developed NCCN Guidelines: Asia Consensus Statements for Breast, Kidney, Non-Small Cell Lung, and Prostate Cancers and Chronic Myelogenous Leukemia.  A JNCCN — Journal of the National Comprehensive Cancer Network supplement will be published this month to illustrate the discoveries of the collective expertise gathered during the NCCN 2nd Annual Middle East & North Africa (MENA) Congress. Approaches to Breast, Colon, Hepatobiliary, Lung, and Prostate Cancers, Non-Hodgkin’s Lymphomas, and Supportive Care will be discussed in the MENA manuscripts of JNCCN.

Without modification, the following NCCN Guidelines, Anal Carcinoma, Colon Cancer, Colorectal Cancer Screening, and Rectal Cancer, have been translated into Japanese by the Translational Research Informatics Center (TRI). TRI intends to translate the Complete Library of NCCN Guidelines over time.  These Guidelines, along with the other region-specific translations described are available on